Pharmacological and surgical treatment of obesity.
作者信息
Shekelle P G, Morton S C, Maglione M, Suttorp M, Tu W, Li Z, Maggard M, Mojica W A, Shugarman L, Solomon V
出版信息
Evid Rep Technol Assess (Summ). 2004 Jul(103):1-6.
Abstract
摘要
相似文献
1
Pharmacological and surgical treatment of obesity.肥胖症的药物治疗与手术治疗
Evid Rep Technol Assess (Summ). 2004 Jul(103):1-6.
2
Obesity.肥胖症
Clin Evid. 2005 Jun(13):707-25.
3
Obesity.肥胖症
Clin Evid. 2003 Dec(10):676-89.
4
Obesity.肥胖症
Clin Evid. 2004 Jun(11):762-76.
5
The pharmacological and surgical management of adults with obesity.肥胖成年人的药物和手术治疗
J Fam Pract. 2014 Jul;63(7 Suppl):S21-6.
6
Orlistat for obesity.用于治疗肥胖症的奥利司他
Med Lett Drugs Ther. 1999 Jun 18;41(1055):55-6.
7
Pharmacologic therapies for obesity.肥胖的药物治疗。
Gastroenterol Clin North Am. 2010 Mar;39(1):69-79. doi: 10.1016/j.gtc.2010.01.001.
8
Challenges in obesity management.肥胖管理中的挑战。
South Med J. 1998 Aug;91(8):710-20. doi: 10.1097/00007611-199808000-00002.
9
Pharmacological treatment of obesity in Europe: waiting for the arrival of the white blackbird.欧洲肥胖症的药物治疗：等待白乌鸫的到来。
Endocrinol Nutr. 2014 Dec;61(10):501-4. doi: 10.1016/j.endonu.2014.11.002.
10
Long-term pharmacotherapy of obesity 2000: a review of efficacy and safety.2000年肥胖症的长期药物治疗：疗效与安全性综述
Arch Intern Med. 2001;161(15):1814-24. doi: 10.1001/archinte.161.15.1814.
引用本文的文献
1
Branch retinal artery occlusion in a 49-year-Old woman taking phentermine.一名49岁服用芬特明的女性发生视网膜分支动脉阻塞。
Am J Ophthalmol Case Rep. 2024 Feb 15;35:102013. doi: 10.1016/j.ajoc.2024.102013. eCollection 2024 Sep.
2
Effectiveness and Characterization of Severely Energy-Restricted Diets in People with Class III Obesity: Systematic Review and Meta-Analysis.重度能量限制饮食对III级肥胖人群的有效性及特征：系统评价与荟萃分析
Behav Sci (Basel). 2019 Dec 7;9(12):144. doi: 10.3390/bs9120144.
3
Laparoscopic Sleeve Gastrectomy Significantly Increases Serum Lipoprotein Lipase Level in Obese Patients.腹腔镜袖状胃切除术显著增加肥胖患者的血清脂蛋白脂肪酶水平。
Obes Facts. 2019;12(3):357-368. doi: 10.1159/000500360. Epub 2019 Jun 5.
4
The value of health and weight loss among primary care patients with moderate to severe obesity: Do quality of life factors have a larger influence than comorbidities?中度至重度肥胖的初级保健患者的健康与体重减轻的价值：生活质量因素的影响是否大于合并症？
Obes Res Clin Pract. 2017 Jan-Feb;11(1):123-126. doi: 10.1016/j.orcp.2016.11.004. Epub 2016 Dec 6.
5
Effect of non-surgical, non-pharmacological weight loss interventions in patients who are obese prior to hip and knee arthroplasty surgery: a rapid review.非手术、非药物减肥干预措施对髋关节和膝关节置换术前肥胖患者的影响：一项快速综述。
Syst Rev. 2015 Sep 27;4:121. doi: 10.1186/s13643-015-0107-2.
6
Moving to a user-driven research paradigm.转向以用户为驱动的研究范式。
EGEMS (Wash DC). 2013 Oct 28;1(2):1017. doi: 10.13063/2327-9214.1017. eCollection 2013.
7
Pharmacotherapy for obesity.肥胖的药物治疗
J Menopausal Med. 2014 Dec;20(3):90-6. doi: 10.6118/jmm.2014.20.3.90. Epub 2014 Dec 24.
8
Sex, race, and consideration of bariatric surgery among primary care patients with moderate to severe obesity.在患有中度至重度肥胖症的初级保健患者中，性别、种族与减肥手术的考量
J Gen Intern Med. 2014 Jan;29(1):68-75. doi: 10.1007/s11606-013-2603-1. Epub 2013 Sep 19.
9
Phentermine and topiramate for the management of obesity: a review.用于肥胖症管理的芬特明和托吡酯：综述
Drug Des Devel Ther. 2011 Apr 5;7:267-78. doi: 10.2147/DDDT.S31443. Print 2013.
10
Expectations for weight loss and willingness to accept risk among patients seeking weight loss surgery.寻求减肥手术的患者对减肥效果的期望和对风险的接受意愿。
JAMA Surg. 2013 Mar;148(3):264-71. doi: 10.1001/jamasurg.2013.1048.
Zotero 插件